Axumin (fluciclovine F 18)

About Blue Earth Diagnostics

Blue Earth Diagnostics is a commercial-stage, private diagnostics company specializing in targeted radiopharmaceuticals for cancer imaging. It leverages a proven track record in rapid development and commercialization to bring novel PET imaging agents to market, aiming to transform clinical decision-making in oncology. As part of the Bracco family, it benefits from global commercial infrastructure and expertise, with a pipeline focused on expanding into new cancer indications. The company's strategy centers on applying its molecular imaging knowledge to drive future therapeutic advancements.

Therapeutic Areas